heparin-induced thrombocytopenia type II - Role of lepirudin;HEPARIN-INDUZIERTE THROMBOZYTOPENIE TYP II. STELLENWERT VON LEPIRUDIN

Krankenhauspharmazie

Volumn 18, Issue 12, 1997, Pages 584-588

  Lipp, Hans Peter ^a,b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Pharmazeutischen Inst Univ T   (Germany)

Author keywords

Comparison with danaparoid; Heparin induced thrombocytopenia type II; Lepirudin; Pharmacological advantages

Indexed keywords

CALCIUM ION; DANAPAROID; HEPARIN; IMMUNOGLOBULIN G; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTIGEN ANTIBODY COMPLEX; DEEP VEIN THROMBOSIS; HUMAN; SHORT SURVEY; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0030819661     PISSN: 01737597     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Bornkessel B Danaparoid bei hepanninuduzierter Thrombozytopenie Typ II. Krankenhauspharmazie 1997;18:239-41.
2. Breddin HK. Neue Aspekte zu Hirudin Med Welt 1997;48:64-6
3. Chong BH, Magnani HN. Orgaran in heparin-induced thrombocytopenia. Haemostasia 1992,22:85
4. Editorials Hirudins: return of the leech? Lancet 1992,340 579-80.
5. Eriksson BI, Kälebo P, Ekman S, et al. Direct thrombin inhibition with rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement. Thromb Haemost 1994;72:227-31.
6. Eriksson BI, Ekman S, Kälebo P, et al. Prevention of deep vein thrombosis after total hip replacement. Direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996;347:635-9.
7. Greinacher A. Heparin-induzierte Thrombozytope-nien. Internist 1996;37 1172-8.
8. Kernkes-Matthes B. Heparin-indizterte Thrombozytopenie Arzneimitteltherapie 1997;15:212-4.
9. Lipp HP. Heparine, Heparinoide und Hirudoide bei Lungenembolie und Thrombosen. Pharm Ztg 1997;142:11-8.
10. Magnani HN Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993;70: 554-61.
11. Markwardt F The development of hirudin as an antithrombotic drug. Thromb Res 1994,74:1-23.
12. Phillips DE, Payne DK, Mills GM Heparin-induced thrombotic thrombocytopenia. Ann Pharmacother 1994;28:43-6.
13. Schiele F, Vuillemenot A, Kramarz P, et al. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia. Am J Haematol 1995;50:20-5.
14. Vanholder R, Camez A, Veys N, et al. Pharmacokinetics of recombinant hirudin in hemodialyzed endstage renal failure patients Thromb Haemost 1997;77:650-5
15. Velten U, Mücke T. Heparin-induzierte Thrombozytopenie. Anästhesiol Intensivmed 1996,2(37):76-80.
16. Warkentin TE, Levine MN, Hirsh J, et al Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 1995;332:1330-5.